Artrya Ltd
AYA
Company Profile
Business description
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
Contact
Sector
Healthcare
Stock type
Industry
Health Information Services
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Is our ASX best idea still attractive after shares surge?
Shares rose over 21% following the results.
stocks
Unconventional wisdom: A controversial income pick
Rigid definitions of income and growth shares may be holding investors back.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,747.60 | 32.70 | -0.37% |
| CAC 40 | 8,006.22 | 33.19 | 0.42% |
| DAX 40 | 21,911.74 | 124.74 | 0.57% |
| Dow JONES (US) | 44,444.30 | 140.90 | 0.32% |
| FTSE 100 | 8,767.80 | 67.27 | 0.77% |
| HKSE | 21,521.98 | 388.44 | 1.84% |
| NASDAQ | 19,733.71 | 210.31 | 1.08% |
| Nikkei 225 | 38,801.17 | 14.15 | 0.04% |
| NZX 50 Index | 12,876.35 | 25.84 | -0.20% |
| S&P 500 | 6,068.40 | 42.41 | 0.70% |
| S&P/ASX 200 | 8,482.80 | 28.60 | -0.34% |
| SSE Composite Index | 3,322.17 | 18.50 | 0.56% |